Search

Your search keyword '"Viswanath, Omar"' showing total 35 results
Start Over Author "Viswanath, Omar" Journal psychopharmacology bulletin
35 results on '"Viswanath, Omar"'

5. MDMA to Treat PTSD in Adults.

Author

Latimer, Dustin, Stocker, Michael D., Sayers, Kia, Green, Jackson, Kaye, Adam M., Abd-Elsayed, Alaa, Cornett, Elyse M., Kaye, Alan D., Varrassi, Giustino, Viswanath, Omar, and Urits, Ivan

Published
2021

8. Lamotrigine and Stevens-Johnson Syndrome Prevention.

Author

Edinoff, Amber N., Nguyen, Long H., Jo Fitz-Gerald, Mary, Crane, Erin, Lewis, Kyle, Pierre, Samantha St, Kaye, Alan D., Kaye, Adam M., Kaye, Jessica S., Rachel, Rachel J., Gennuso, Sonja A., Varrassi, Giustino, Viswanath, Omar, and Urits, Ivan

Published
2021

27. Lumateperone for the Treatment of Schizophrenia.

Author

Edinoff, Amber, Natalie Wu, de Boisblanc, Charles, Feltner, Catherine Olivia, Norder, Mariah, Tzoneva, Vesela, Kaye, Adam M., Cornett, Elyse M., Kaye, Alan D., Viswanath, Omar, and Urits, Ivan

Published
2020

35. Intrathecal Morphine Delivery at Cisterna Magna to Control Refractory Cancer-Related Pain: A Prospective Cohort Study.

Author

Sun C, Wang YT, Dai YJ, Liu ZH, Yang J, Cheng ZQ, Dong DS, Wang CF, Zhao GL, Lu GJ, Song T, Jin Y, Sun LL, Kaye AD, Urits I, Viswanath O, and Sun YH

Subjects
Cisterna Magna, Humans, Injections, Spinal, Morphine therapeutic use, Prospective Studies, Quality of Life, Cancer Pain drug therapy, Neoplasms complications, Neoplasms drug therapy, Pain, Intractable drug therapy, Pain, Intractable etiology
Abstract

Background: For patients suffering from primary or metastatic cancer above the middle thoracic vertebrae, refractory pain management still remains a great challenge. Theoretically, inserting a catheter tip into the cisterna magna may be a promising solution. However, at present, there have been no reliable data regarding this novel technique. We therefore investigated the efficacy and safety of an advanced approach for pain relief in a specific population., Methods: Thirty participants from two hospitals received the intrathecal deliveries of opioid to either one of two sites: cisterna magna (n = 15) or lower thoracic region (n = 15). Pain relief (visual analogue scale, VAS), quality of life (short form (36) health survey, SF-36) as well as depression (self-rating depression scale, SDS) were assessed in the follow-up visits and compared between the two groups., Results: Patients receiving intrathecal morphine delivery to cisterna magna achieved greater pain improvement indicated as significant decrease of VAS scores at day 1 and 7, and achieved better improvement in physical function (day 7 and 30), role physical (day 7 and 30), body pain (day 7, 30 and 90), general health (day 7, 30 and 90), vitality (day 7, 30 and 90), social function (day 90), role emotional (day 7 and 90), mental health (day 7, 30 and 90) and SDS (day 1 and 7)., Conclusions: Intrathecal morphine delivery to cisterna magna might be an effective and safe technique for patients suffering from cancer at the middle thoracic vertebrae or above to control refractory pain. Trial registration: No. ChiCTR-ONN-17010681., (Copyright © 1964–2019 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.)

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results